Related articles:

Supernus Pharmaceuticals Inc.: Supernus Announces Record Fourth Quarter and Full Year 2016 Financial Results
February 28, 2017
February 28, 2017

Supernus Pharmaceuticals Inc.: Supernus to Host Fourth Quarter and Full Year 2016 Earnings Conference Call
February 13, 2017
February 13, 2017

Supernus Pharmaceuticals Inc.: Supernus Announces Resignation of Dr. James Barrett from Board of Directors; Charles W. Newhall, III Elected Chairman
August 12, 2016
August 12, 2016

Supernus Pharmaceuticals Inc.: Supernus Announces Second Quarter 2016 Financial Results
August 02, 2016
August 2, 2016

Supernus Pharmaceuticals Inc.: Supernus Announces First Quarter 2016 Financial Results
May 03, 2016
May 3, 2016

Supernus Pharmaceuticals Inc.: Supernus to Host First Quarter 2016 Earnings Conference Call
April 19, 2016
April 19, 2016

Supernus Pharmaceuticals Inc.: Supernus Announces Record Fourth Quarter and Full Year 2015 Financial Results
March 02, 2016
March 2, 2016

Supernus Pharmaceuticals Inc.: Supernus Announces Distribution of Common Stock by NEA
December 04, 2015
December 4, 2015

Supernus Pharmaceuticals Inc.: Supernus to Attend Guggenheim Securities Boston Healthcare Conference
December 02, 2015
December 2, 2015

Supernus Pharmaceuticals Inc.: Supernus Announces Third Quarter 2015 Financial Results and Raises 2015 Guidance
November 03, 2015
November 3, 2015

Supernus Pharmaceuticals Inc.: Supernus Announces Issuance of Fifth U.S. Patent Protecting Oxtellar XR(R)
September 02, 2015
September 2, 2015

Supernus Pharmaceuticals Inc.: Supernus Announces Second Quarter 2015 Financial Results
August 04, 2015
August 4, 2015

Supernus Pharmaceuticals Inc.: Supernus Announces First Quarter 2015 Financial Results
May 05, 2015
May 5, 2015

Supernus Pharmaceuticals Inc.: Supernus Announces Issuance of Sixth U.S. Patent Protecting Trokendi XR(R)
April 02, 2015
April 2, 2015

Supernus Pharmaceuticals Inc.: Georges Gemayel, Ph.D., Joins Supernus Board of Directors
March 23, 2015
March 23, 2015

Supernus Pharmaceuticals Inc.: Supernus Announces Fourth Quarter and Full Year 2014 Results
March 10, 2015
March 10, 2015

Supernus Pharmaceuticals Inc.: Supernus Sues TWi for Infringement of Oxtellar XR(R) Patents
January 21, 2015
January 21, 2015

Supernus Pharmaceuticals Inc.: Supernus Sues Par for Infringement of Trokendi XR(R) Patents
January 16, 2015
January 16, 2015

Supernus Pharmaceuticals Inc.: Supernus Announces Issuance of Fifth U.S. Patent Protecting Trokendi XR(R)
November 24, 2014
November 24, 2014

Supernus Pharmaceuticals Inc.: Supernus Sues Zydus for Infringement of Trokendi XR(R) Patents
November 21, 2014
November 21, 2014

Supernus Pharmaceuticals Inc.: Supernus Announces Third Quarter 2014 Results
November 11, 2014
November 11, 2014

Supernus Pharmaceuticals Inc.: Supernus Announces Issuance of Fourth U.S. Patent Protecting Trokendi XR(R)
November 07, 2014
November 7, 2014

Supernus Pharmaceuticals Inc.: Supernus Sues Actavis for Infringement of Trokendi XR(R) Patents
October 02, 2014
October 2, 2014

Supernus Pharmaceuticals Inc.: Supernus Announces Issuance of Fourth US Patent Protecting Oxtellar XR(R)
September 04, 2014
September 4, 2014

Supernus Pharmaceuticals Inc.: Supernus Announces Second Quarter 2014 Results
August 11, 2014
August 11, 2014

Supernus Pharmaceuticals Inc.: Supernus Announces First Quarter 2014 Results
May 12, 2014
May 12, 2014

Supernus Pharmaceuticals Inc.: Supernus Announces Fourth Quarter and Full Year 2013 Results
March 12, 2014
March 12, 2014

Supernus Pharmaceuticals Inc.: Supernus Announces Resignation of Board Member
December 24, 2013
December 24, 2013

Supernus Pharmaceuticals Inc.: Supernus Pharmaceuticals Reports Third Quarter 2013 Financial Results
November 12, 2013
November 12, 2013

Pin It on Pinterest

Share This